Empower & Confirm Diagnosis
Practices are evolving—not only to meet the challenges of resistant head lice, but in response to changing healthcare dynamics. As a complete solution, Spinosad Topical Suspension 0.9% can help.4
Nix® is a registered trademark of Prestige Consumer Healthcare Inc.
- Gellatly KJ, Krim S,Palenchar DJ, et al. Expansion of the knockdown resistance frequency map for human head lice (phthiraptera: pediculidae) in the United States using quantitative sequencing. Journal of Medical Entomology, 2016:1-7.
- Meinking TL, Serrano L, Hard B, et al. Comparative in vitro pediculicidal efficacy of treatments in a resistant head lice population in the United States. Arch Dermatol. 2002;138:220-224.
- DP West, Head Lice Treatment Costs and the Impact on Managed Care, Amer J of Managed Care, September 1, 2004.
- Spinosad Topical Suspension 0.9% Prescribing Information.